- Home
- CADL vs GDEV Comparison
CADL vs GDEV Comparison
Compare CADL & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GDEV
- Stock Information
- Founded
- CADL 1999
- GDEV 2009
- Country
- CADL United States
- GDEV Cyprus
- Employees
- CADL N/A
- GDEV N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- CADL Health Care
- GDEV Technology
- Exchange
- CADL Nasdaq
- GDEV Nasdaq
- Market Cap
- CADL 234.8M
- GDEV N/A
- IPO Year
- CADL 2021
- GDEV N/A
- Fundamental
- Price
- CADL $4.76
- GDEV $15.45
- Analyst Decision
- CADL Strong Buy
- GDEV Buy
- Analyst Count
- CADL 4
- GDEV 2
- Target Price
- CADL $21.00
- GDEV $70.00
- AVG Volume (30 Days)
- CADL 864.6K
- GDEV 37.4K
- Earning Date
- CADL 05-13-2025
- GDEV 05-27-2025
- Dividend Yield
- CADL N/A
- GDEV N/A
- EPS Growth
- CADL N/A
- GDEV N/A
- EPS
- CADL N/A
- GDEV 1.38
- Revenue
- CADL N/A
- GDEV $420,933,000.00
- Revenue This Year
- CADL N/A
- GDEV $4.73
- Revenue Next Year
- CADL N/A
- GDEV $16.15
- P/E Ratio
- CADL N/A
- GDEV $11.17
- Revenue Growth
- CADL N/A
- GDEV N/A
- 52 Week Low
- CADL $3.79
- GDEV $8.60
- 52 Week High
- CADL $14.60
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- CADL 41.42
- GDEV 62.08
- Support Level
- CADL $4.80
- GDEV $10.25
- Resistance Level
- CADL $5.34
- GDEV $18.33
- Average True Range (ATR)
- CADL 0.33
- GDEV 1.43
- MACD
- CADL 0.10
- GDEV 0.79
- Stochastic Oscillator
- CADL 42.09
- GDEV 64.36
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.